As with many wild and dramatic stories, the story of Theranos and ex-CEO Elizabeth Holmes gets multiple adaptations. Jennifer Lawrence led by bad blood, which was just picked up by Apple, is likely to get the most attention. (Expect to get a lot of Oscar love, like the last Adam McKay films, vice And The Big Short.) But don’t count the Hulu mini-series, leakage. First announced in 2019 with Kate McKinnon as celebrity Elizabeth Holmes, it will now star Amanda Seyfried when it premieres March 3, 2022.
Judging from the first round of photos, Seyfried certainly captured the wide-eyed attraction of Holmes. It’s also amazing to see the great Naveen Andrews (lost, sense 8) as Ramesh “Sunny” Balwani, former COO of Theranos and ex-boyfriend of Holmes. According to Hulu, the series will follow an “incredible story of ambition and fame so grossly wrong. How did the world’s youngest self-made billionaire lose it all in the blink of an eye?”
Theranos has managed to raise more than $700 million from investors due to its seemingly supernatural device, the Edison. It was a blood-screening machine that was supposed to test for a wide variety of diseases. But of course, it was all a lie. Reports from The Wall Street Journal Others revealed that the company’s technology never actually worked. In the end, the Securities and Exchange Commission accused Theranos, Holmes, and Balwany of committing “widespread fraud.”
HBO documentary by Alex Gibney, the inventorHe did a useful job of covering the drama about Theranos, and the unusual magic of Holmes. But there’s also a lot of ground to cover in a dramatic adaptation.
All products recommended by Engadget are handpicked by our editorial team, independently of the parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.